#1 ordered compound in our catalog. Two of the most-studied recovery peptides combined in a single vial. 150+ combined preclinical references. 99.2% HPLC-verified purity.
The Wolverine Blend is a synergistic combination of the two most-studied recovery peptides in preclinical research: BPC-157 (Body Protection Compound 157, 5mg) and TB-500 (Thymosin Beta-4 fragment, 5mg) — combined in a single lyophilized vial. With 150+ combined preclinical references, this blend represents the most extensively studied peptide pairing for musculoskeletal recovery models.
BPC-157 is a 15-amino-acid peptide fragment originally isolated from gastric juice, studied for tissue repair signaling and angiogenesis regulation. TB-500 is a synthetic fragment of Thymosin Beta-4, studied for its role in cell migration, actin regulation, and systemic tissue repair signaling. Together, researchers examine their complementary and potentially synergistic mechanisms.
The Wolverine Blend is classified as a research-use-only compound. It is not FDA-approved for any therapeutic indication. All references below describe preclinical (in vitro or animal model) research contexts, not human clinical outcomes.
Research examines the synergistic effects of BPC-157 and TB-500 in tissue repair models — exploring complementary signaling pathways including VEGF activation, actin polymerization, and fibroblast migration in musculoskeletal recovery contexts.
Preclinical studies examine the pairing of BPC-157's tendon/ligament signaling with TB-500's systemic repair cascade in models of joint recovery, muscle tissue repair, and connective tissue regeneration.
Both peptides independently demonstrate effects on new blood vessel formation in preclinical models. Combined research explores potentially amplified vascularization signaling through complementary VEGF and NO pathway interactions.
Published research examines both peptides' effects on inflammatory marker modulation — BPC-157 through GI-cytoprotective pathways and TB-500 through actin-sequestering anti-inflammatory mechanisms in tissue injury models.
The Wolverine Blend combines BPC-157 (5mg) and TB-500 (5mg) in a single lyophilized vial. It's SMART MD's #1 ordered compound — pairing the two most-studied recovery peptides in preclinical research for synergistic musculoskeletal recovery models. 150+ combined preclinical references. 99.2% HPLC verified.
Yes — BPC-157 and TB-500 are commonly paired in preclinical research protocols. They operate through complementary mechanisms: BPC-157 primarily signals through VEGF and NO pathways for localized tissue repair, while TB-500 acts systemically through actin regulation and cell migration. Published research examines their potentially synergistic effects when combined.
A single-vial blend ensures precise ratio consistency (1:1 by mass), eliminates reconstitution variability between two separate vials, and simplifies research protocol preparation. SMART MD tests the final blended product — not just individual components — ensuring both peptides maintain stability and purity in combination.
Research-grade Wolverine Blend with 3-lab COA verification is available exclusively at SMART MD Peptides. Every batch is publicly verifiable at smartmdpeptides.com/verify. Individual BPC-157 and TB-500 are also available separately in multiple sizes.
Lyophilized (unreconstituted) Wolverine Blend should be stored at -20°C, protected from light. Once reconstituted, store at 2-8°C and use within the timeframe specified on your lot-specific documentation.
Check the COA before you buy. Compare it against any other supplier's documentation.